RAPT Therapeutics, Inc.
RAPTDelisted Mar 3, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001673772
RAPT Therapeutics, Inc. was delisted on Mar 3, 2026; its insiders filed their last Form 4 on Mar 5, 2026; 106 institutions reported holding it in 13F filings for Q4 2025, worth $1.02B in total; no superinvestor held it.
Q2 2024 vs. Q1 2024
How the institutions holding RAPT Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 122 | 2 | 103 | −17 |
| Shares | 32.0M | 37.6K | 31.8M | −122.2K (−0.4%) |
| Value | $287.2M | $336.4K | $97.0M | −$189.8M (−66.2%) |
2 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (23)
Institutions that held RAPT Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (40)
Institutions that held RAPT Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
Not filed for Q2 2024 yet (2)
Institutions that held RAPT Therapeutics, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 37,459 | $336.4K |
| Cutler Group LP | 100 | $0 |